Frontiers | Targeting KRAS Mutant in Non-Small Cell Lung Cancer: Novel Insights Into Therapeutic Strategies
Clinical characteristics and prognostic value of the KRAS mutation in Chinese colorectal cancer patients - Ye Yuan, Yingting Liu, Ye Wu, Junling Zhang, Chunti Shen, Feng Zhang, Changping Wu, Wenwei Hu, 2021
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text
KRas mutations spectrum in 670 colorectal cancers | Download Table
IJMS | Free Full-Text | Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward?
KRAS Codon 12 Mutation is Associated with More Aggressive Invasiveness | OTT
Cancers | Free Full-Text | Targeting Oncogenic KRAS in Non-Small-Cell Lung Cancer
Prevalence of KRAS, NRAS and BRAF mutations in patients with colorectal... | Download Scientific Diagram
RAS mutations: impact on treatment outcome | Colorectal Cancer
KRAS mutation: from undruggable to druggable in cancer | Signal Transduction and Targeted Therapy
KRAS Mutation in Colon Cancer: A Marker of Resistance to EGFR-I Therapy | Annals of Surgical Oncology
Frontiers | Targeting KRAS: The Elephant in the Room of Epithelial Cancers
Frontiers | New Horizons in KRAS-Mutant Lung Cancer: Dawn After Darkness
The Prognostic Impact of KRAS G12C Mutation in Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Observational Study - Chida - 2021 - The Oncologist - Wiley Online Library
Frequencies of KRAS mutations measured using methods with different... | Download Scientific Diagram
:max_bytes(150000):strip_icc()/kras-g12c-mutation-in-nsclc-4843957-v3-456bf340786c481b857d044b6a8cb307-b4828f2507074811b94472745e488299.png "KRAS Positive Lung Cancer: Testing and Management")
KRAS Positive Lung Cancer: Testing and Management
Predictive and prognostic biomarkers with therapeutic targets in advanced colorectal cancer
The current understanding on the impact of KRAS on colorectal cancer - ScienceDirect
Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX | Scientific Reports
Life | Free Full-Text | Integrated Decision-Making in the Treatment of Colon-Rectal Cancer: The Case of KRAS-Mutated Tumors
Integrated multi-omics characterization of KRAS mutant colorectal cancer
Immune modulatory effects of oncogenic KRAS in cancer | Nature Communications
BRAF Mutation in Colorectal Cancer | IntechOpen
Mutant KRAS as a critical determinant of the therapeutic response of colorectal cancer - ScienceDirect
